Knight Therapeutics | GUD - 税前利润

股票价格

7.55

每天变化

-0.10 -1.31%

每月一次

21.97%

每年

35.06%

Q2 预测

7.26

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD -0.09

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 771.93M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	税前利润	更改		日
Acasti Pharma	USD -2.31M		1.38M	2025-12
Akebia Therapeutics	USD -11.24M		12.39M	2025-12
Alaunos Therapeutics	USD -7.84M		633K	2023-12
Aurora Cannabis	CAD -1.58M		48.55M	2025-12
Avita Medical	AUD -11.64M		12.13M	2025-12
Canopy Growth	CAD -62.26M		60.84M	2025-12
Cronos Group	USD 31.78M		70.78M	2025-09
Dianthus Therapeutics	USD -64.43M		27.67M	2025-12
Ionis Pharmaceuticals	USD -228M		99M	2025-12
IQVIA Holdings	USD 6.16B		5.84B	2025-09
Knight Therapeutics	CAD -1.92M		13.69M	2025-09
Moderna	USD -187M		631M	2025-09
Omeros	USD -65.12M		21.27M	2024-06
Organigram Holdings	CAD -41.72M		25.52M	2025-09
Organon & Co	USD 243M		14M	2025-09
Revvity	USD 55.68M		115.97M	2025-09
Tectonic Therapeutic	USD -18.97M		63K	2025-12
Tilray	USD -39.96M		39.19M	2025-09
Viatris	USD -7.9M		209.2M	2025-09
Xeris Pharmaceuticals	USD 11.08M		10.46M	2025-12